Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • usfda

    Tag: usfda

    You Searched For "usfda"
    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Alkem Labs closes USFDA inspection of Baddi, Daman facility with 2 observations

    Medical Dialogues Bureau2 Nov 2019 9:45 AM IST
    New Delhi: Drugmaker Alkem Laboratories (Alkem Labs) recently informed that the company has received 2 observations from the US health regulator for...
    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Medical Dialogues Bureau2 Nov 2019 9:30 AM IST
    Zantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Medical Dialogues Bureau1 Nov 2019 2:11 PM IST
    New Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns

    Medical Dialogues Bureau31 Oct 2019 9:45 AM IST
    Novartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings...
    Biogen, Alkermes get USFDA nod for multiple sclerosis drug Vumerity

    Biogen, Alkermes get USFDA nod for multiple sclerosis drug Vumerity

    Medical Dialogues Bureau31 Oct 2019 9:25 AM IST
    The new drug, Vumerity, was approved to treat relapsing forms of multiple sclerosis, a disabling autoimmune disease that damages the central nervous...
    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    IOL Chemicals and Pharma Ibuprofen manufacturing facilities in Barnala clears USFDA inspection

    Medical Dialogues Bureau30 Oct 2019 2:11 PM IST
    Mumbai: IOL Chemicals and Pharmaceuticals (IOLCP) recently received a communication from US Food and Drug Administration (USFDA) with respect to an...
    New tests shows NO sign of asbestos in recalled JnJ baby powder

    New tests shows NO sign of asbestos in recalled JnJ baby powder

    Medical Dialogues Bureau30 Oct 2019 1:18 PM IST
    But Johnson & Johnson (JnJ) said in a statement that dozens of tests by two outside firms did not detect any asbestos in JnJ's baby powder.New...
    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Dr Reddys Srikakulam plant gets 4 USFDA observations

    Farhat Nasim29 Oct 2019 10:00 AM IST
    The audit of Dr Reddy's API Srikakulam Plant (SEZ) by the United States Food and Drug Administration (USFDA) was completed on Friday, the...
    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Alkem Labs Bioeguivalcnce Center at Taloja clears USFDA inspection

    Medical Dialogues Bureau28 Oct 2019 10:00 AM IST
    "This is to inform that the US FDA had conducted an inspection at Alkem Laboratories Ltd's Bioequivalence Center located at Taloja, Maharashtra from...
    CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug

    CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug

    Farhat Nasim27 Oct 2019 11:30 AM IST
    New Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), recently recommended drugmaker,...
    Shilpa Medicare Telangana facility gets EIR from USFDA

    Shilpa Medicare Telangana facility gets EIR from USFDA

    Medical Dialogues Bureau26 Oct 2019 11:46 AM IST
    "The USFDA has concluded that the inspection classification of Jadcherla facility was "voluntary action indicated". This facility is in an acceptable...
    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Cadila Healthcare arm gets USFDA nod for Haloperidol Decanoate injection to treat schizophrenia

    Medical Dialogues Bureau25 Oct 2019 11:32 AM IST
    Haloperidol is used in the treatment of schizophrenia and for the control of tics and vocal utterances of Tourette syndrome, Cadila Healthcare...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok